mo4ch:>Bayer bets on ‘silver bullet’ defense in Monsanto Roundup cancer litigation | Mo4ch News
German pharmaceutical firm Bayer plans to argue that a $2 billion jury award and thousands of US lawsuits claiming its glyphosate-based weed killer Roundup causes cancer should be dropped.The company points to a US regulatory agency’s provision that the herbicide is not a public health risk. On Wednesday, Bayer said it will argue that the lawsuits, which are brought under state law, conflict with guidance from a federal agency, the US Environmental Protection Agency (EPA).Back in 1985, the watchdog labeled glyphosate a carcinogen, reversing its position later in 1991. Last month, the EPA reaffirmed prior guidance saying that glyphosate is not a carcinogen and not a risk to public health when used in accordance with its current label.Also on rt.comCalifornia jury awards couple $2 billion in Monsanto/Bayer Roundup cancer trialUnder the legal doctrine of preemption, state law claims are barred if they conflict with federal law.“We have very strong arguments that the claims here are preem…